Testosterone potentiated 32P therapy in prostatic carcinoma.
D006801:Humans; D008297:Male; D010166:Palliative Care; D010759:Phosphorus Isotopes / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D013739:Testosterone / Q000627:therapeutic use*
D010759:Phosphorus Isotopes; D013739:Testosterone